✦ LIBER ✦

Clinical usefulness of oral combination chemotherapy of 5′;-deoxy-5-fluorouridine (5′;-DFUR) and cyclophosphamide for metastatic Breast Cancer

✍ Scribed by Toshinari Yamashita; Hiroko Yamashita; Yukashi Itoh; Shoji Karamatsu; Kazuko Itoh; Yasuo Hara; Yoshiaki Ando; Hiroshi Sugiura; Tatsuya Kuzushima; Tatsuya Toyama; Hiroji Iwata; Shunzo Kobayashi; Hirotaka Iwase

Book ID: 111854267
Publisher: Springer Japan
Year: 2006
Tongue: English
Weight: 483 KB
Volume: 13
Category: Article
ISSN: 1340-6868
DOI: 10.2325/jbcs.13.334

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The potential for oral combination chemo

The potential for oral combination chemotherapy of 5′-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer

✍ Yoshimoto, M; Tada, K; Tokudome, N; Kutomi, G; Tanabe, M; Goto, T; Nishimura, S; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

The efficacy of long-term oral chemother

The efficacy of long-term oral chemotherapy with 5′-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer

✍ Toshiaki Iba; Akio Kidokoro; Masaki Fukunaga; Kazuyoshi Sugiyama; Nobuyoshi Aiha 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 267 KB

Positive Response to Oral Chemoendocrine

Positive Response to Oral Chemoendocrine Combination Therapy Using 5″-Deoxy-5-Fluorouridine for Locally Advanced Breast Cancer with Carcinomatous Pleurisy: Report of a Case

✍ On Suzuki; Yoshiaki Sekishita; Tuneo Shiono; Satoshi Kondo; Hiroyuki Kato 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 280 KB

Combination chemotherapy with 5-Fluorour

Combination chemotherapy with 5-Fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer—an open Phase II study

✍ K. Kolarié; V. Potrebica; D. Vukas; Z. Mechl; B. Sopkova 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 483 KB

PP-5-16 A Study of Postoperative Adjuvan

PP-5-16 A Study of Postoperative Adjuvant Chemotherapy of 5′-DFUR in Breast Cancer Patients (1st Report) — On Compliance and Safety — “The 5′-BC Study Group” (5′-DFUR Adjuvant Chemotherapy for Breast Cancer Study Group)

✍ H. Koyama; O. Abe; J. Uchino; W. Hayasaka; R. Abe; M. Izuo; K. Enomoto; T. Tomin 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Combination chemoimmunotherapy of metast

Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG

✍ Gabriel N. Hortobagyi; Jordan U. Gutterman; George R. Blumenschein; Charles K. T 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB